Study protocol of the glow study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics—a prospective multicenter cohort study

HIGHLIGHTS

• who: Mark P. van Opijnen from the Department of Medical Oncology, Utrecht University Medical Center, Utrecht, The Netherlands have published the article: Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnosticsu2014a prospective multicenter cohort study, in the Journal: (JOURNAL)
• what: The GLOW study aims to provide the scientific evidence for changing the SOC diagnostics for patients with a recurrent glioblastoma by investigating complete genome diagnostics to maximize treatment options for this patient group. The aim of the GLOW study is to determine the percentage of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.